Transplantation, Homologous
"Transplantation, Homologous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals.
| Descriptor ID |
D014184
|
| MeSH Number(s) |
E04.936.864
|
| Concept/Terms |
Transplantation, Homologous- Transplantation, Homologous
- Transplantation, Allogeneic
- Homografting
- Homologous Transplantation
- Allogeneic Transplantation
- Allografting
|
Below are MeSH descriptors whose meaning is more general than "Transplantation, Homologous".
Below are MeSH descriptors whose meaning is more specific than "Transplantation, Homologous".
This graph shows the total number of publications written about "Transplantation, Homologous" by people in this website by year, and whether "Transplantation, Homologous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 8 | 8 |
| 1996 | 0 | 8 | 8 |
| 1997 | 1 | 6 | 7 |
| 1998 | 1 | 4 | 5 |
| 1999 | 0 | 6 | 6 |
| 2000 | 2 | 2 | 4 |
| 2001 | 1 | 10 | 11 |
| 2002 | 1 | 12 | 13 |
| 2003 | 1 | 7 | 8 |
| 2004 | 1 | 4 | 5 |
| 2005 | 2 | 12 | 14 |
| 2006 | 5 | 12 | 17 |
| 2007 | 3 | 14 | 17 |
| 2008 | 0 | 13 | 13 |
| 2009 | 0 | 9 | 9 |
| 2010 | 3 | 11 | 14 |
| 2011 | 1 | 19 | 20 |
| 2012 | 2 | 23 | 25 |
| 2013 | 2 | 15 | 17 |
| 2014 | 0 | 16 | 16 |
| 2015 | 1 | 17 | 18 |
| 2016 | 1 | 12 | 13 |
| 2017 | 3 | 11 | 14 |
| 2018 | 2 | 15 | 17 |
| 2019 | 2 | 19 | 21 |
| 2020 | 1 | 15 | 16 |
| 2021 | 0 | 12 | 12 |
| 2022 | 0 | 7 | 7 |
| 2023 | 0 | 5 | 5 |
| 2024 | 1 | 8 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transplantation, Homologous" by people in Profiles.
-
Budesonide, Added to PTCy-Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell Transplantation. Am J Hematol. 2025 Mar; 100(3):383-392.
-
Transplant in ALL: who, when, and how? Hematology Am Soc Hematol Educ Program. 2024 12 06; 2024(1):93-101.
-
Measurable residual disease testing and allogeneic hematopoietic cell transplantation for AML: adapting Pre-MEASURE to clinical practice. Bone Marrow Transplant. 2025 Feb; 60(2):128-134.
-
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia. Bone Marrow Transplant. 2025 Feb; 60(2):154-160.
-
Outcomes and genetic dynamics of acute myeloid leukemia at first relapse. Haematologica. 2024 Nov 01; 109(11):3543-3556.
-
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia. Bone Marrow Transplant. 2025 Feb; 60(2):144-153.
-
Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunity. Blood Adv. 2024 10 08; 8(19):5137-5145.
-
High activity of the new myeloablative regimen of gemcitabine/clofarabine/busulfan for allogeneic transplant for aggressive lymphomas. Bone Marrow Transplant. 2024 Dec; 59(12):1754-1762.
-
A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-Like B-Cell Acute Lymphoblastic Leukemia in First Complete Remission. Transplant Cell Ther. 2024 Dec; 30(12):1197-1205.
-
Chronic graft-versus-host disease: unresolved complication or ancient history? Blood. 2024 09 26; 144(13):1363-1373.